Blood glucose profiles in East Asian and Caucasian injection-naive patients with type 2 diabetes inadequately controlled on oral medication: a pooled analysis-Reference-Cited by-同舟云学术

Blood glucose profiles in East Asian and Caucasian injection-naive patients with type 2 diabetes inadequately controlled on oral medication: a pooled analysis

Published:2018-10-02 Issue:8 Volume:34 Page:e3062
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Zhang Xiao Mei¹,Li Peng Fei²,Hou Jia Ning²^ORCID,Ji Li Nong³^ORCID

Affiliation:

1. Department of Endocrinology and Metabolism; Peking University International Hospital; Beijing China

2. Medical Department; Lilly Suzhou Pharmaceutical Co. Ltd; Shanghai China

3. Department of Endocrinology and Metabolism; Peking University People's Hospital; Beijing China

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.3062/fullpdf

Reference26 articles.

1. Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus;Bonora;Diabetologia,2006

2. Metrics for glycaemic control-from HbA1c to continuous glucose monitoring;Kovatchev;Nat Rev Endocrinol,2017

3. International Diabetes Foundation 2011 Guideline for Management of PostMeal Glucose in Diabetes https://www.idf.org/our-activities/advocacy-awareness/resources-and-tools/82:management-of-postmeal-glucose.html

4. Postprandial hyperglycemia and insulin sensitivity differ among lean young adults of different ethnicities;Dickinson;J Nutr,2002

5. Diabetes in Asia: epidemiology, risk factors, and pathophysiology;Chan;JAMA,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Historical and More Common Nongenetic Movement Disorders From Asia;Journal of Movement Disorders;2023-09-30

2. Focus on a special tool for postprandial glucose control: Ultra rapid lispro;Chinese Science Bulletin;2023-06-01

3. Ultra rapid lispro improves postprandial glucose control versus lispro in combination with insulin glargine/degludec in adults with type 2 diabetes: a prospective, randomized, double-blind, phase 3 trial;Science Bulletin;2022-09

4. Improved glycaemic control and weight benefit with iGlarLixi versus insulin glargine 100 U/ mL in Chinese people with type 2 diabetes advancing their therapy from basal insulin plus oral antihyperglycaemic drugs: Results from the LixiLan‐L‐CN randomized controlled trial;Diabetes, Obesity and Metabolism;2022-07-25

5. DUAL I China: Improved glycemic control with IDegLira versus its individual components in a randomized trial with Chinese participants with type 2 diabetes uncontrolled on oral antidiabetic drugs;Journal of Diabetes;2022-06